ArticleOncology letters2014

Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute.

Wen-Xi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.